 | C6J | Name: | 2-(2,2-diphosphonoethyl)-1-methylpyridin-1-ium | Formula: | C8 H14 N O6 P2 | SMILES: | O=P(O)(O)C(Cc1cccc[n+]1C)P(=O)(O)O | InChi: | InChI=1S/C8H13NO6P2/c1-9-5-3-2-4-7(9)6-8(16(10,11)12)17(13,14)15/h2-5,8H,6H2,1H3,(H3-,10,11,12,13,14,15)/p+1 | Definition date: | 2017-09-14 | Last modified: | 2024-04-25 | Release date: | 2017-12-13 | Identifier: | 2-(2,2-diphosphonoethyl)-1-methylpyridin-1-ium |
|
 | C6M | Name: | 2-(2,2-diphosphonoethyl)-1-propylpyridin-1-ium | Formula: | C10 H18 N O6 P2 | SMILES: | O=P(O)(O)C(Cc1cccc[n+]1CCC)P(=O)(O)O | InChi: | InChI=1S/C10H17NO6P2/c1-2-6-11-7-4-3-5-9(11)8-10(18(12,13)14)19(15,16)17/h3-5,7,10H,2,6,8H2,1H3,(H3-,12,13,14,15,16,17)/p+1 | Definition date: | 2017-09-14 | Last modified: | 2024-04-25 | Release date: | 2017-12-13 | Identifier: | 2-(2,2-diphosphonoethyl)-1-propylpyridin-1-ium |
|
 | 50L | Name: | (5S)-2-amino-8-(5-O-phosphono-beta-D-ribofuranosyl)imidazo[1,2-a][1,3,5]triazin-4(8H)-one | Formula: | C10 H14 N5 O8 P | SMILES: | O=P(O)(O)OCC1OC(N2C=CN3C(=O)N=C(N)N=C32)C(O)C1O | InChi: | InChI=1S/C10H14N5O8P/c11-8-12-9-14(1-2-15(9)10(18)13-8)7-6(17)5(16)4(23-7)3-22-24(19,20)21/h1-2,4-7,16-17H,3H2,(H2,11,13,18)(H2,19,20,21)/t4-,5-,6-,7-/m1/s1 | Definition date: | 2015-07-08 | Last modified: | 2024-04-25 | Release date: | 2015-08-12 | Identifier: | (5S)-2-amino-8-(5-O-phosphono-beta-D-ribofuranosyl)imidazo[1,2-a][1,3,5]triazin-4(8H)-one |
|
 | EQ1 | Name: | 2-amino-1-[(R)-{[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl]-3-[(S)-{[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl]-1H-imidazol-3-ium | Formula: | C23 H30 N13 O14 P2 | SMILES: | NC1=Nc2c(ncn2C2OC(COP(=O)(O)[n+]3ccn(c3N)P(=O)(O)OCC3OC(n4cnc5c4N=C(N)NC5=O)C(O)C3O)C(O)C2O)C(=O)N1 | InChi: | InChI=1S/C23H29N13O14P2/c24-21-29-15-9(17(41)31-21)27-5-33(15)19-13(39)11(37)7(49-19)3-47-51(43,44)35-1-2-36(23(35)26)52(45,46)48-4-8-12(38)14(40)20(50-8)34-6-28-10-16(34)30-22(25)32-18(10)42/h1-2,5-8,11-14,19-20,26,37-40H,3-4H2,(H8,24,25,29,30,31,32,41,42,43,44,45,46)/p+1/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1 | Definition date: | 2018-01-25 | Last modified: | 2024-04-25 | Release date: | 2018-05-30 | Identifier: | 2-amino-1-[(R)-{[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl]-3-[(S)-{[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl]-1H-imidazol-3-ium (non-preferred name) |
|
 | E9A | Name: | 1-methyl-3-(2-{[(1R,2R,5S)-5-methyl-2-(propan-2-yl)cyclohexyl]oxy}-2-oxoethyl)-2-(phenoxymethyl)-1H-1,3-benzimidazol-3-ium | Formula: | C27 H35 N2 O3 | SMILES: | CC(C)C1CCC(C)CC1OC(=O)C[n+]1c2ccccc2n(C)c1COc1ccccc1 | InChi: | InChI=1S/C27H35N2O3/c1-19(2)22-15-14-20(3)16-25(22)32-27(30)17-29-24-13-9-8-12-23(24)28(4)26(29)18-31-21-10-6-5-7-11-21/h5-13,19-20,22,25H,14-18H2,1-4H3/q+1/t20-,22+,25+/m0/s1 | Definition date: | 2017-12-13 | Last modified: | 2024-04-25 | Release date: | 2018-12-12 | Identifier: | 1-methyl-3-(2-{[(1R,2R,5S)-5-methyl-2-(propan-2-yl)cyclohexyl]oxy}-2-oxoethyl)-2-(phenoxymethyl)-1H-1,3-benzimidazol-3-ium |
|
 | 8QJ | Name: | (1S)-1-carboxy-2-[2-(hydroxysulfanyl)-1H-imidazol-4-yl]-N,N,N-trimethylethan-1-aminium | Formula: | C9 H16 N3 O3 S | SMILES: | OSc1nc(CC(C(=O)O)[N+](C)(C)C)c[NH]1 | InChi: | InChI=1S/C9H15N3O3S/c1-12(2,3)7(8(13)14)4-6-5-10-9(11-6)16-15/h5,7H,4H2,1-3H3,(H2-,10,11,13,14,15)/p+1/t7-/m0/s1 | Definition date: | 2017-03-01 | Last modified: | 2024-04-25 | Release date: | 2018-03-07 | Identifier: | (1S)-1-carboxy-2-[2-(hydroxysulfanyl)-1H-imidazol-4-yl]-N,N,N-trimethylethan-1-aminium |
|
 | DE4 | Name: | (4-{[(3R)-1-benzylpyrrolidin-3-yl]amino}-2-nitrophenyl)methanol | Formula: | C18 H21 N3 O3 | SMILES: | [O-][N+](=O)c1cc(ccc1CO)NC1CCN(Cc2ccccc2)C1 | InChi: | InChI=1S/C18H21N3O3/c22-13-15-6-7-16(10-18(15)21(23)24)19-17-8-9-20(12-17)11-14-4-2-1-3-5-14/h1-7,10,17,19,22H,8-9,11-13H2/t17-/m1/s1 | Definition date: | 2017-10-24 | Last modified: | 2024-04-25 | Release date: | 2018-10-03 | Identifier: | (4-{[(3R)-1-benzylpyrrolidin-3-yl]amino}-2-nitrophenyl)methanol |
|
 | DF7 | Name: | [4-({(3R)-1-[(1H-indol-3-yl)methyl]pyrrolidin-3-yl}amino)-2-nitrophenyl]methanol | Formula: | C20 H22 N4 O3 | SMILES: | [O-][N+](=O)c1cc(ccc1CO)NC1CCN(Cc2c[NH]c3ccccc23)C1 | InChi: | InChI=1S/C20H22N4O3/c25-13-14-5-6-16(9-20(14)24(26)27)22-17-7-8-23(12-17)11-15-10-21-19-4-2-1-3-18(15)19/h1-6,9-10,17,21-22,25H,7-8,11-13H2/t17-/m1/s1 | Definition date: | 2017-10-25 | Last modified: | 2024-04-25 | Release date: | 2018-10-03 | Identifier: | [4-({(3R)-1-[(1H-indol-3-yl)methyl]pyrrolidin-3-yl}amino)-2-nitrophenyl]methanol |
|
 | J4D | Name: | N-[2-hydroxy-3-nitro-5-(nitrosulfonyl)phenyl]-N'-(pentafluorophenyl)urea | Formula: | C13 H5 F5 N4 O8 S | SMILES: | O=S(=O)([N+]([O-])=O)c1cc(c(O)c(NC(=O)Nc2c(F)c(F)c(F)c(F)c2F)c1)[N+]([O-])=O | InChi: | InChI=1S/C13H5F5N4O8S/c14-6-7(15)9(17)11(10(18)8(6)16)20-13(24)19-4-1-3(31(29,30)22(27)28)2-5(12(4)23)21(25)26/h1-2,23H,(H2,19,20,24) | Definition date: | 2018-08-09 | Last modified: | 2024-04-25 | Release date: | 2018-11-28 | Identifier: | N-[2-hydroxy-3-nitro-5-(nitrosulfonyl)phenyl]-N'-(pentafluorophenyl)urea |
|
 | XS0 | Name: | namodenoson | Formula: | C18 H18 Cl I N6 O4 | SMILES: | CNC(=O)[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc23 | InChi: | InChI=1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-3-2-4-9(20)5-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1 | Synonyms: | (2~{S},3~{S},4~{R},5~{R})-5-[2-chloranyl-6-[(3-iodanylphenyl)methylamino]purin-9-yl]-~{N}-methyl-3,4-bis(oxidanyl)oxolane-2-carboxamide | Definition date: | 2023-11-09 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | (2~{S},3~{S},4~{R},5~{R})-5-[2-chloranyl-6-[(3-iodanylphenyl)methylamino]purin-9-yl]-~{N}-methyl-3,4-bis(oxidanyl)oxolane-2-carboxamide |
|
 | A1AAR | Name: | N-(6-amino-5-methylpyridin-3-yl)-2-[(2R,5S)-2-(4-hydroxyphenyl)-5-methylpiperidin-1-yl]-2-oxoacetamide | Formula: | C20 H24 N4 O3 | SMILES: | CC1CCC(c2ccc(O)cc2)N(C1)C(=O)C(=O)Nc1cc(C)c(N)nc1 | InChi: | InChI=1S/C20H24N4O3/c1-12-3-8-17(14-4-6-16(25)7-5-14)24(11-12)20(27)19(26)23-15-9-13(2)18(21)22-10-15/h4-7,9-10,12,17,25H,3,8,11H2,1-2H3,(H2,21,22)(H,23,26)/t12-,17+/m0/s1 | Definition date: | 2023-12-30 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | N-(6-amino-5-methylpyridin-3-yl)-2-[(2R,5S)-2-(4-hydroxyphenyl)-5-methylpiperidin-1-yl]-2-oxoacetamide |
|
 | A1AAU | Name: | 5-{2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl](oxo)acetamido}pyridine-3-carboxamide | Formula: | C20 H22 N4 O3 | SMILES: | CC1CCC(c2ccccc2)N(C1)C(=O)C(=O)Nc1cc(cnc1)C(N)=O | InChi: | InChI=1S/C20H22N4O3/c1-13-7-8-17(14-5-3-2-4-6-14)24(12-13)20(27)19(26)23-16-9-15(18(21)25)10-22-11-16/h2-6,9-11,13,17H,7-8,12H2,1H3,(H2,21,25)(H,23,26)/t13-,17+/m0/s1 | Definition date: | 2023-12-31 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | 5-{2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl](oxo)acetamido}pyridine-3-carboxamide |
|
 | A1AAV | Name: | N-(6-amino-5-methylpyridin-3-yl)-2-[(2R,5S)-2-(1,3-benzothiazol-5-yl)-5-methylpiperidin-1-yl]-2-oxoacetamide | Formula: | C21 H23 N5 O2 S | SMILES: | Cc1cc(cnc1N)NC(=O)C(=O)N1CC(C)CCC1c1cc2ncsc2cc1 | InChi: | InChI=1S/C21H23N5O2S/c1-12-3-5-17(14-4-6-18-16(8-14)24-11-29-18)26(10-12)21(28)20(27)25-15-7-13(2)19(22)23-9-15/h4,6-9,11-12,17H,3,5,10H2,1-2H3,(H2,22,23)(H,25,27)/t12-,17+/m0/s1 | Synonyms: | TNG908 | Definition date: | 2023-12-31 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | N-(6-amino-5-methylpyridin-3-yl)-2-[(2R,5S)-2-(1,3-benzothiazol-5-yl)-5-methylpiperidin-1-yl]-2-oxoacetamide |
|
 | ZQF | Name: | 2-[(4-butylbenzene-1-sulfonyl)amino]-5-[(3-{4-[(4-butylbenzene-1-sulfonyl)amino]-3-carboxyanilino}-3-oxopropyl)carbamoyl]benzoic acid | Formula: | C38 H42 N4 O10 S2 | SMILES: | O=S(=O)(Nc1ccc(NC(=O)CCNC(=O)c2ccc(NS(=O)(=O)c3ccc(CCCC)cc3)c(c2)C(=O)O)cc1C(=O)O)c1ccc(CCCC)cc1 | InChi: | InChI=1S/C38H42N4O10S2/c1-3-5-7-25-9-15-29(16-10-25)53(49,50)41-33-19-13-27(23-31(33)37(45)46)36(44)39-22-21-35(43)40-28-14-20-34(32(24-28)38(47)48)42-54(51,52)30-17-11-26(12-18-30)8-6-4-2/h9-20,23-24,41-42H,3-8,21-22H2,1-2H3,(H,39,44)(H,40,43)(H,45,46)(H,47,48) | Definition date: | 2023-03-20 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | 2-[(4-butylbenzene-1-sulfonyl)amino]-5-[(3-{4-[(4-butylbenzene-1-sulfonyl)amino]-3-carboxyanilino}-3-oxopropyl)carbamoyl]benzoic acid |
|
 | A1AHF | Name: | N-[(2S)-3-oxo-1-(beta-L-talopyranosyloxy)octadecan-2-yl]docosanamide | Formula: | C46 H89 N O8 | SMILES: | CCCCCCCCCCCCCCCC(=O)C(COC1OC(CO)C(O)C(O)C1O)NC(=O)CCCCCCCCCCCCCCCCCCCCC | InChi: | InChI=1S/C46H89NO8/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-26-28-30-32-34-36-42(50)47-39(38-54-46-45(53)44(52)43(51)41(37-48)55-46)40(49)35-33-31-29-27-25-23-16-14-12-10-8-6-4-2/h39,41,43-46,48,51-53H,3-38H2,1-2H3,(H,47,50)/t39-,41-,43+,44+,45+,46-/m0/s1 | Definition date: | 2024-03-07 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | N-[(2S)-3-oxo-1-(beta-L-talopyranosyloxy)octadecan-2-yl]docosanamide |
|
 | A1AM9 | Name: | (3R)-3-(3-fluorophenoxy)-1-methylpyrrolidin-2-one | Formula: | C11 H12 F N O2 | SMILES: | CN1CCC(Oc2cc(F)ccc2)C1=O | InChi: | InChI=1S/C11H12FNO2/c1-13-6-5-10(11(13)14)15-9-4-2-3-8(12)7-9/h2-4,7,10H,5-6H2,1H3/t10-/m1/s1 | Definition date: | 2024-04-15 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | (3R)-3-(3-fluorophenoxy)-1-methylpyrrolidin-2-one |
|
 | A1AMY | Name: | N-[(2-fluorophenyl)methyl]oxan-4-amine | Formula: | C12 H16 F N O | SMILES: | Fc1ccccc1CNC1CCOCC1 | InChi: | InChI=1S/C12H16FNO/c13-12-4-2-1-3-10(12)9-14-11-5-7-15-8-6-11/h1-4,11,14H,5-9H2 | Definition date: | 2024-04-15 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | N-[(2-fluorophenyl)methyl]oxan-4-amine |
|
 | A1AMZ | Name: | (4R)-imidazo[1,2-b]pyridazine-3-sulfonamide | Formula: | C6 H6 N4 O2 S | SMILES: | NS(=O)(=O)c1cnc2cccnn12 | InChi: | InChI=1S/C6H6N4O2S/c7-13(11,12)6-4-8-5-2-1-3-9-10(5)6/h1-4H,(H2,7,11,12) | Definition date: | 2024-04-15 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | (4R)-imidazo[1,2-b]pyridazine-3-sulfonamide |
|
 | A1ANA | Name: | 4-amino-N-cyclobutyl-1-methyl-1H-pyrazole-3-carboxamide | Formula: | C9 H14 N4 O | SMILES: | Nc1cn(C)nc1C(=O)NC1CCC1 | InChi: | InChI=1S/C9H14N4O/c1-13-5-7(10)8(12-13)9(14)11-6-3-2-4-6/h5-6H,2-4,10H2,1H3,(H,11,14) | Definition date: | 2024-04-15 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | 4-amino-N-cyclobutyl-1-methyl-1H-pyrazole-3-carboxamide |
|
 | A1ANB | Name: | 2-hydroxy-N-(2,4,6-trimethylphenyl)acetamide | Formula: | C11 H15 N O2 | SMILES: | O=C(Nc1c(C)cc(C)cc1C)CO | InChi: | InChI=1S/C11H15NO2/c1-7-4-8(2)11(9(3)5-7)12-10(14)6-13/h4-5,13H,6H2,1-3H3,(H,12,14) | Definition date: | 2024-04-15 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | 2-hydroxy-N-(2,4,6-trimethylphenyl)acetamide |
|
 | A1ANE | Name: | 5-phenyl-1,3,4-oxadiazol-2-ol | Formula: | C8 H6 N2 O2 | SMILES: | Oc1nnc(o1)c1ccccc1 | InChi: | InChI=1S/C8H6N2O2/c11-8-10-9-7(12-8)6-4-2-1-3-5-6/h1-5H,(H,10,11) | Definition date: | 2024-04-15 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | 5-phenyl-1,3,4-oxadiazol-2-ol |
|
 | A1ANF | Name: | 1-(2-chlorophenyl)-2-(pyrrolidin-1-yl)ethan-1-one | Formula: | C12 H14 Cl N O | SMILES: | O=C(CN1CCCC1)c1ccccc1Cl | InChi: | InChI=1S/C12H14ClNO/c13-11-6-2-1-5-10(11)12(15)9-14-7-3-4-8-14/h1-2,5-6H,3-4,7-9H2 | Definition date: | 2024-04-15 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | 1-(2-chlorophenyl)-2-(pyrrolidin-1-yl)ethan-1-one |
|
 | VY8 | Name: | 1-[2-(dimethylamino)ethyl]-3-(2-methoxyphenyl)thiourea | Formula: | C12 H19 N3 O S | SMILES: | COc1ccccc1NC(=S)NCCN(C)C | InChi: | InChI=1S/C12H19N3OS/c1-15(2)9-8-13-12(17)14-10-6-4-5-7-11(10)16-3/h4-7H,8-9H2,1-3H3,(H2,13,14,17) | Definition date: | 2023-04-13 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | 1-[2-(dimethylamino)ethyl]-3-(2-methoxyphenyl)thiourea |
|
 | X9W | Name: | (2R)-(dimethylphosphoryl)(hydroxy)acetic acid | Formula: | C4 H9 O4 P | SMILES: | O=C(O)C(O)P(C)(C)=O | InChi: | InChI=1S/C4H9O4P/c1-9(2,8)4(7)3(5)6/h4,7H,1-2H3,(H,5,6)/t4-/m1/s1 | Definition date: | 2023-10-26 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | (2R)-(dimethylphosphoryl)(hydroxy)acetic acid |
|
 | XAI | Name: | (2R)-2,3-dihydroxy-3-methylbutanoic acid | Formula: | C5 H10 O4 | SMILES: | O=C(O)C(O)C(C)(C)O | InChi: | InChI=1S/C5H10O4/c1-5(2,9)3(6)4(7)8/h3,6,9H,1-2H3,(H,7,8)/t3-/m0/s1 | Definition date: | 2023-10-26 | Last modified: | 2024-04-19 | Release date: | 2024-04-24 | Identifier: | (2R)-2,3-dihydroxy-3-methylbutanoic acid |
|